Frequently Asked Questions:
Bovine Respiratory Disease (BRD)

Understanding The most costly Disease of Cattle Production

Learn from these commonly asked questions how you can build BRD resilience in calves, identify signs of the disease and key considerations as you make treatment decisions.

Causes of BRD

Detecting BRD

Preventing BRD

Treating BRD

Always work with your local veterinarian who knows your goals and health challenges in your area.

Explore the complete line of Vaccines from Merck Animal Health

SenseHub Feedlot is not intended to diagnose, treat, cure, or prevent any disease in animals. For the diagnosis, treatment, cure, or prevention of diseases in animals, you should consult your veterinarian. The accuracy of the data collected and presented through this product is not intended to match that of medical devices or scientific measurement devices.

BANAMINE TRANSDERMAL (flunixin transdermal solution): NOT FOR HUMAN USE. KEEP OUT OF REACH OF CHILDREN. Milk that has been taken during treatment and for 48 hours after treatment must not be used for human consumption. Cattle must not be slaughtered for human consumption within 8 days of the last treatment. Not for use in replacement dairy heifers 20 months of age or older or dry dairy cows; use in these cattle may cause drug residues in milk and/or calves born to these cows or heifers. Not for use in beef and dairy bulls intended for breeding over 1 year of age, beef calves less than 2 months of age, dairy calves, and veal calves. Do not use within 48 hours of expected parturition. Approved only as a single topical dose in cattle. For complete information on Banamine® Transdermal, see accompanying product package insert.

RESFLOR GOLD (Florfenicol and Flunixin Meglumine): Not for use in humans. Keep out of reach of children. Do not use in animals that have shown hypersensitivity to florfenicol or flunixin. Avoid direct contact with skin, eyes and clothing as product contains materials that can be irritating. Animals intended for human consumption must not be slaughtered within 38 days of treatment. This product is not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows. A withdrawal period has not been established in pre-ruminating calves. Do not use in calves to be processed for veal. Not for use in animals intended for breeding purposes. See package insert for complete information.

1. Smith, DR. Risk factors for bovine respiratory disease in beef cattle. Anim. Health Res. Rev. Dec. 2020. 21(2):149-152.

2. Sanderson, MW, Dargatz, DA, Wagner, BA. Risk factors for initial respiratory disease in United States’ feedlots based on producer-collected daily morbidity counts. Can. Vet. J. April 2008. 49(4):373-8.